These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25904511)

  • 1. Regulatory agencies hold the key to improving Cochrane reviews of drugs.
    Schroll J; Bero L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):ED000098. PubMed ID: 25904511
    [No Abstract]   [Full Text] [Related]  

  • 2. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistakeholder Advice at the European Medicines Agency: Is It Still Needed?
    Vamvakas S; Moseley J; Vetter T
    Clin Pharmacol Ther; 2019 Apr; 105(4):819-821. PubMed ID: 30811587
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on Sood et al.: "Cochrane systematic reviews in acupuncture: methodological diversity in database searching".
    Lao L
    J Altern Complement Med; 2005 Aug; 11(4):723-4. PubMed ID: 16131299
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues regarding systematic review reports and trial heterogeneity.
    Meads C; Sheffield D
    J Nerv Ment Dis; 2005 Jun; 193(6):424-5; author reply 425-6. PubMed ID: 15920385
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory perspectives on data monitoring.
    O'Neill RT
    Stat Med; 2002 Oct; 21(19):2831-42. PubMed ID: 12325099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated Approval of Anticancer Drugs: Lessons Learned From the Example of Olaratumab.
    Papachristos A; Ratain MJ
    Clin Pharmacol Ther; 2021 Jul; 110(1):29-31. PubMed ID: 33147355
    [No Abstract]   [Full Text] [Related]  

  • 8. The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.
    Milton MN; Horvath CJ
    Toxicol Pathol; 2009 Apr; 37(3):363-71. PubMed ID: 19246571
    [No Abstract]   [Full Text] [Related]  

  • 9. Methodological developments in searching for studies for systematic reviews: past, present and future?
    Lefebvre C; Glanville J; Wieland LS; Coles B; Weightman AL
    Syst Rev; 2013 Sep; 2():78. PubMed ID: 24066664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?
    Teixeira T; Kweder SL; Saint-Raymond A
    Clin Pharmacol Ther; 2020 Mar; 107(3):507-513. PubMed ID: 31449664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible Contribution of Drug Approval Summaries Published by Drug Regulatory Authorities on Scientific Discussion and Drug Development.
    Tanese K; Yamori T
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):6-10. PubMed ID: 31608600
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methodological recommendations of the Regulatory Agencies].
    Torres F; Calvo G; Pontes C
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():72-6. PubMed ID: 16464431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engaging patients in medicines regulation: a tale of two agencies.
    Mavris M; Furia Helms A; Bere N
    Nat Rev Drug Discov; 2019 Nov; 18(12):885-886. PubMed ID: 31780842
    [No Abstract]   [Full Text] [Related]  

  • 14. Protocol design.
    Wilensky AJ
    Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086
    [No Abstract]   [Full Text] [Related]  

  • 15. European Medicines Agency's Priority Medicines Scheme at 2 Years: An Evaluation of Clinical Studies Supporting Eligible Drugs.
    Neez E; Hwang TJ; Sahoo SA; Naci H
    Clin Pharmacol Ther; 2020 Mar; 107(3):541-552. PubMed ID: 31591708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochrane systematic reviews in acupuncture: methodological diversity in database searching.
    Sood A; Sood R; Bauer BA; Ebbert JO
    J Altern Complement Med; 2005 Aug; 11(4):719-22. PubMed ID: 16131298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systematic reviews of studies of diagnostic test accuracy].
    Moreno G G; Pantoja C T
    Rev Med Chil; 2009 Feb; 137(2):303-7. PubMed ID: 19543656
    [No Abstract]   [Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone and cardiovascular risk.
    Psaty BM; Furberg CD
    N Engl J Med; 2007 Jun; 356(24):2522-4. PubMed ID: 17517854
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.